Helus Pharma notches successful Phase 3 depression readout
Helus Pharma, part of the budding class of psychedelics companies, said its lead drug improved depression symptoms compared to placebo, but investors appeared slightly skittish about the safety profile. The company said
comments(0)
5-min edit window · permanent after that